Page last updated: 2024-09-04

docetaxel anhydrous and oxadiazoles

docetaxel anhydrous has been researched along with oxadiazoles in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(oxadiazoles)
Trials
(oxadiazoles)
Recent Studies (post-2010) (oxadiazoles)
12,1103,2166,9206,0572572,359

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cui, Q; Dai, M; Dong, Z; Huang, C; Josephraj, S; Kyei-Baffour, K; Liu, JY; Peery, R; Zhang, JT1

Other Studies

1 other study(ies) available for docetaxel anhydrous and oxadiazoles

ArticleYear
A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells.
    Bioorganic & medicinal chemistry, 2022, 07-01, Volume: 65

    Topics: Apoptosis; Cell Line, Tumor; Dimerization; Docetaxel; Humans; Hydrazones; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Oxadiazoles; Prodrugs; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Survivin

2022
chemdatabank.com